XML 42 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Stock Incentive Plans (Tables)
6 Months Ended
Jun. 30, 2020
Summary of Stock Option Activity

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Options Outstanding

​

​

​

​

​

 

​

    

​

    

Weighted

    

Weighted

    

​

​

 

​

​

Number

​

Average

​

Average Remaining

​

Aggregate

 

​

​

of

​

Exercise

​

Contractual

​

Intrinsic

 

​

​

Shares

​

Price

​

Term (Years)

​

Value

 

Balances at December 31, 2019

    

16,288

    

$

3.56

    

​

​

​

​

​

Options granted

 

210

​

$

9.00

​

​

​

​

​

​

Options canceled

 

(287)

​

$

5.35

​

​

​

​

​

​

Options exercised

 

(3,460)

​

$

3.36

​

​

​

​

​

​

Balances at June 30, 2020

 

12,751

​

$

3.66

 

6.98

​

$

71,487

​

​

​

​

​

​

​

​

​

​

​

​

​

Options exercisable at June 30, 2020

 

8,619

​

$

3.28

 

6.71

​

$

51,668

​

Schedule of Assumptions Used to Estimate Fair Value of Options

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Stock Options

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

​

Six Months Ended

​

​

​

June 30, 

 

​

June 30, 

 

​

   

2020

​

   

2019

 

​

2020

​

   

2019

 

Dividend yield

 

—

%

 

—

%

 

—

%

 

—

%

Risk-free interest rate

 

0.28

%

 

2.07

%

 

0.28

%

 

2.15

%

Expected volatility

 

69.3

%

 

56.1

%

 

69.3

%

 

56.1

%

Expected term (years)

 

4.00

​

 

4.00

​

 

4.00

​

 

4.00

​

Schedule of Stock-Based Compensation Expense by Line Item

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Six Months Ended

​

​

​

June 30, 

​

June 30, 

​

​

    

2020

   

2019

​

2020

   

2019

​

Research and development (1)

​

$

5,298

​

$

1,128

​

$

9,260

​

$

5,074

​

Sales and marketing

​

 

1,013

​

 

55

​

 

1,888

​

 

881

​

General and administrative

​

 

1,795

​

 

852

​

 

3,340

​

 

2,887

​

Total stock-based compensation expense (2)

​

$

8,106

​

$

2,035

​

$

14,488

​

$

8,842

​

(1)For the three and six months ended June 30, 2020, stock-based compensation expense recorded in research and development includes $486 and $630 from PSUs classified as liabilities.
(2)Stock-based compensation expense for the three and six months ended June 30, 2019 included a reversal of previously accrued expense of $2,526 due to a decrease in the vesting probability of certain performance-based equity awards.
Schedule of compensation expense related to unvested awards

The following table summarizes total compensation expense related to unvested awards not yet recognized as of June 30, 2020:

​

​

​

​

​

​

Unrecognized Compensation

​

​

Expense for Unvested

​

​

Awards

Stock options

​

$

8,276

RSUs

​

​

33,063

PSUs (1)

​

​

7,048

PSOs

​

​

638

Total unrecognized compensation expense

​

$

49,025

(1)The unrecognized compensation expense for PSUs classified as equity and vesting in fiscal years 2022 and 2023, except for PSUs classified as liabilities, is excluded in the table above as the Company does not have a reasonable basis upon which to estimate the vesting probability of such awards in those future periods.
Restricted stock units ("RSUs")  
Summary of Company's Performance-based Awards

​

​

​

​

​

​

​

​

​

​

​

​

​

    

    

    

Weighted

​

Weighted

​

​

​

​

​

Number of

​

Average

​

Average Remaining

​

​

Aggregate

​

​

Units

​

Grant Date

​

Contractual

​

​

Intrinsic

​

   

Outstanding

   

Fair Value

​

Term (Years)

​

​

Value

Awarded and unvested, December 31, 2019

 

3,951

​

$

5.66

​

​

​

​

​

Granted

 

3,013

​

$

6.40

​

​

​

​

​

Vested

 

(885)

​

$

4.88

​

​

​

​

​

Forfeited

 

(190)

​

$

5.78

​

​

​

​

​

Awarded and unvested, June 30, 2020

 

5,889

​

$

6.15

​

1.73

​

$

54,592

Performance stock units ("PSUs")  
Summary of Company's Performance-based Awards

​

​

​

​

​

​

​

​

​

​

​

​

​

    

    

    

Weighted

​

Weighted

​

​

​

​

​

Number of

​

Average

​

Average Remaining

​

​

Aggregate

​

​

Units

​

Grant Date

​

Contractual

​

​

Intrinsic

​

   

Outstanding

   

Fair Value

​

Term (Years)

​

​

Value

Awarded and unvested, December 31, 2019

​

5,417

​

$

6.06

​

​

​

​

​

Vested

​

(276)

​

$

3.61

​

​

​

​

​

Forfeited

​

(1,370)

​

$

6.85

​

​

​

​

​

Awarded and unvested, June 30, 2020

​

3,771

​

$

5.95

​

1.24

​

$

34,953

​

​

​

​

​

​

​

​

​

​

​

PSUs expected to vest at June 30, 2020

​

1,625

​

$

5.56

​

0.63

​

$

15,068

Performance stock options ("PSOs")  
Summary of Stock Option Activity

​

​

​

​

​

​

​

​

​

​

​

​

​

    

    

    

Weighted

​

Weighted

​

​

​

​

​

Number of

​

Average

​

Average Remaining

​

​

Aggregate

​

​

Shares

​

Exercise

​

Contractual

​

​

Intrinsic

​

   

Outstanding

   

Price

​

Term (Years)

​

​

Value

Balance as of December 31, 2019

​

6,583

​

$

4.54

​

​

​

​

​

Canceled

​

(1,377)

​

$

6.18

​

​

​

​

​

Exercised

​

(948)

​

$

3.61

​

​

​

​

​

Balance as of June 30, 2020

​

4,258

​

$

4.21

​

7.53

​

$

21,531

​

​

​

​

​

​

​

​

​

​

​

PSOs expected to vest at June 30, 2020

​

526

​

$

3.60

​

7.35

​

$

2,984

PSOs exercisable at June 30, 2020

​

2,800

​

$

3.59

​

7.30

​

$

15,892